Selepressin in Septic Shock: A Step Toward Decatecholaminization?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Selepressin, a novel selective vasopressin VCritical care (London, England) · 2017
   Trial
2. Alternatives to norepinephrine in septic shock: Which agents and when?Journal of intensive medicine · 2022
   Review
3. Biological Connection of Psychological Stress and Polytrauma under Intensive Care: The Role of Oxytocin and Hydrogen Sulfide.International journal of molecular sciences · 2021
   Review
4. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.Journal of intensive care · 2020
   Article
5. Vasopressin and its analogues in shock states: a review.Annals of intensive care · 2020
   Review
6. A global perspective on vasoactive agents in shock.Intensive care medicine · 2018
   Review
7. The apelinergic system as an alternative to catecholamines in low-output septic shock.Critical care (London, England) · 2018
   Article
8. Angiotensin II: a new therapeutic option for vasodilatory shock.Therapeutics and clinical risk management · 2018
   Review
9. Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.Current topics in medicinal chemistry · 2018
   Review
10. Cardiac dysfunction in sepsis.Intensive care medicine · 2016
    Article

Corrections and comments

• Comment on
  A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.2016

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as